Author:
O'Connor Michael Glenn,Seegmiller Adam
Subject
Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health
Reference28 articles.
1. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation;Ramsey;N Engl J Med,2011
2. Discovery of N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, ivacaftor), a potent and orally bioavailable CFTR potentiator;Hadida;J Med Chem,2014
3. Association of cystic fibrosis with abnormalities in fatty acid metabolism;Freedman;N Engl J Med,2004
4. A mechanism accounting for the low cellular level of linoleic acid in cystic fibrosis and its reversal by DHA;Al-Turkmani;J Lipid Res,2008
5. Increased Delta5- and Delta6-desaturase, cyclooxygenase-2, and lipoxygenase-5 expression and activity are associated with fatty acid and eicosanoid changes in cystic fibrosis;Njoroge;Biochim Biophys Acta,2011
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献